Wu W - Search Results

1

Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.

Liao N, Li C, Cao L, Chen Y, Ren C, Chen X, Mok H, Wen L, Li K, Wang Y, Zhang Y, Li Y, Lv J, Cao F, Luo Y, Li H, Wu W, Balch CM, Giuliano AE. Liao N, et al. Among authors: wu w. Breast Cancer. 2023 Jan;30(1):77-87. doi: 10.1007/s12282-022-01400-x. Epub 2022 Sep 21. Breast Cancer. 2023. PMID: 36129636

2

Tumor immune microenvironment of NSCLC with EGFR exon 20 insertions may predict efficacy of first-line ICI-combined regimen.

Liu KJ, Li HR, Tan QQ, Jiang T, Peng KC, Chen HJ, Zhou Q, Zhang XC, Zheng Z, Chen SY, Zheng X, Zheng HB, Mao BB, Gong LL, Chen XW, Wu W, Wu YL, Jia J, Yang JJ. Liu KJ, et al. Among authors: wu w, wu yl. Lung Cancer. 2024 Sep;195:107933. doi: 10.1016/j.lungcan.2024.107933. Epub 2024 Aug 22. Lung Cancer. 2024. PMID: 39191079 Free article.

3

Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non-small-cell lung cancer.

Zhang W, Han W, Yu B, Zhao X, Lu G, Wu W, Zhang Y. Zhang W, et al. Among authors: wu w. Thorac Cancer. 2022 Jun;13(11):1642-1650. doi: 10.1111/1759-7714.14432. Epub 2022 Apr 24. Thorac Cancer. 2022. PMID: 35466584 Free PMC article.

4

Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.

Liu SY, Dong S, Yang XN, Liao RQ, Jiang BY, Wang Q, Ben XS, Qiao GB, Lin JT, Yan HH, Yan LX, Nie Q, Tu HY, Wang BC, Yang JJ, Zhou Q, Li HR, Liu K, Wu W, Liu SM, Zhong WZ, Wu YL. Liu SY, et al. Among authors: wu w, wu yl. Signal Transduct Target Ther. 2023 Dec 6;8(1):442. doi: 10.1038/s41392-023-01700-4. Signal Transduct Target Ther. 2023. PMID: 38057314 Free PMC article. Clinical Trial.

5

5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.

Xiao Z, Wu W, Wu C, Li M, Sun F, Zheng L, Liu G, Li X, Yun Z, Tang J, Yu Y, Luo S, Sun W, Feng X, Cheng Q, Tao X, Wu S, Tao J. Xiao Z, et al. Among authors: wu w, wu c, wu s. Mol Oncol. 2021 Jan;15(1):138-150. doi: 10.1002/1878-0261.12833. Epub 2020 Nov 14. Mol Oncol. 2021. PMID: 33107199 Free PMC article.

6

Identification of a Novel MPRIP-ROS1 Fusion and Clinical Efficacy of Crizotinib in an Advanced Lung Adenocarcinoma Patient: A Case Report.

Shu Y, Li H, Shang H, Chen J, Su X, Le W, Lei Y, Tao L, Zou C, Wu W. Shu Y, et al. Among authors: wu w. Onco Targets Ther. 2020 Oct 13;13:10387-10391. doi: 10.2147/OTT.S270961. eCollection 2020. Onco Targets Ther. 2020. PMID: 33116618 Free PMC article.

7

Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion.

Zhang X, Feng J, Su X, Lei Y, Wu W, Cheng X. Zhang X, et al. Among authors: wu w. Onco Targets Ther. 2020 Dec 9;13:12667-12671. doi: 10.2147/OTT.S283617. eCollection 2020. Onco Targets Ther. 2020. PMID: 33328738 Free PMC article.

8

Mutant Allele Frequency-Based Intra-Tumoral Genetic Heterogeneity Related to the Tumor Shrinkage Mode After Neoadjuvant Chemotherapy in Breast Cancer Patients.

Zheng CH, Liu ZY, Yuan CX, Dong XY, Li HM, Wang JJ, Zhang ZP, Liu HY, Ding XY, Wu W, Wang RR, Wang YS. Zheng CH, et al. Among authors: wu w. Front Med (Lausanne). 2021 Mar 31;8:651904. doi: 10.3389/fmed.2021.651904. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33869255 Free PMC article.

9

Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.

Lu D, Wu X, Wu W, Wu S, Li H, Zhang Y, Yan X, Zhai J, Dong X, Feng S, Zhang X, Sun F, Wang S, Cai K. Lu D, et al. Among authors: wu x, wu w, wu s. Cell Death Dis. 2023 Dec 19;14(12):843. doi: 10.1038/s41419-023-06329-3. Cell Death Dis. 2023. PMID: 38114477 Free PMC article.

10

Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report.

Lin Y, Lei Y, Li L, Su X, Tian Q, Wu W. Lin Y, et al. Among authors: wu w. Onco Targets Ther. 2022 Jul 28;15:831-836. doi: 10.2147/OTT.S372134. eCollection 2022. Onco Targets Ther. 2022. PMID: 35923471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,186 results

Search Page

Filters